Literature DB >> 34067345

Anti-SARS-CoV-2 Activity of Surgical Masks Infused with Quaternary Ammonium Salts.

Gary S Selwyn1, Chunyan Ye2, Steven B Bradfute2.   

Abstract

The SARS-CoV-2 pandemic has highlighted the need for protective and effective personal protective equipment (PPE). Research has shown that SARS-CoV-2 can survive on personal protective equipment, such as commonly used surgical masks. Methods are needed to inactivate virus on contaminated material. We show here that embedding viral-disinfecting compounds during the manufacturing of surgical masks inactivates a high dose (up to 1 × 105 pfu) of live, authentic SARS-CoV-2 within minutes.

Entities:  

Keywords:  SARS-CoV-2; inactivation; masks; personal protective equipment

Mesh：

Substances：

Year:  2021        PMID： 34067345     DOI： 10.3390/v13060960

Source DB:  PubMed          Journal:  Viruses        ISSN： 1999-4915            Impact factor:   5.048


  12 in total

Review 1.  Quaternary ammonium biocides: efficacy in application.

Authors:  Charles P Gerba
Journal:  Appl Environ Microbiol       Date:  2014-10-31       Impact factor: 4.792

2.  Evaluation of Virex® II 256 and Virex® Tb as Disinfectants of the Dimorphic Fungi Coccidioides immitis and Coccidioides posadasii.

Authors:  Natalie M Mitchell; D Mitchell Magee; Thomas E Grys; Douglas F Lake
Journal:  Appl Biosaf       Date:  2018-12-20

3.  Survival and disinfection of an enveloped surrogate virus on Tyvek suits used for health care personal protective equipment.

Authors:  Travis W Brown; Weiyu Chen; Lisa M Casanova
Journal:  Am J Infect Control       Date:  2016-09-02       Impact factor: 2.918

4.  Inactivation of Listeria monocytogenes by disinfectants and bacteriophages in suspension and stainless steel carrier tests.

Authors:  N Chaitiemwong; W C Hazeleger; R R Beumer
Journal:  J Food Prot       Date:  2014-12       Impact factor: 2.077

5.  Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019.

Authors:  Steven B Bradfute; Ivy Hurwitz; Alexandra V Yingling; Chunyan Ye; Qiuying Cheng; Timothy P Noonan; Jay S Raval; Nestor R Sosa; Gregory J Mertz; Douglas J Perkins; Michelle S Harkins
Journal:  J Infect Dis       Date:  2020-10-13       Impact factor: 5.226

6.  Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses.

Authors:  M Khalid Ijaz; Raymond W Nims; Sifang Steve Zhou; Kelly Whitehead; Vanita Srinivasan; Tanya Kapes; Semhar Fanuel; Jonathan H Epstein; Peter Daszak; Joseph R Rubino; Julie McKinney
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

7.  Correlation of SARS-CoV-2 Neutralizing Antibodies to an Automated Chemiluminescent Serological Immunoassay.

Authors:  David G Grenache; Chunyan Ye; Steven B Bradfute
Journal:  J Appl Lab Med       Date:  2021-03-01

8.  The effect of temperature on persistence of SARS-CoV-2 on common surfaces.

Authors:  Shane Riddell; Sarah Goldie; Andrew Hill; Debbie Eagles; Trevor W Drew
Journal:  Virol J       Date:  2020-10-07       Impact factor: 4.099

9.  Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids.

Authors:  Gerard Kian-Meng Goh; A Keith Dunker; James A Foster; Vladimir N Uversky
Journal:  Microb Pathog       Date:  2020-03-31       Impact factor: 3.848

10.  The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication.

Authors:  Elizabeth C Clarke; Robert A Nofchissey; Chunyan Ye; Steven B Bradfute
Journal:  Glycobiology       Date:  2021-05-03       Impact factor: 5.954
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.